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INTRODUCTION
Heparin is a member of the glycosaminoglycan (GAG) family. Glycosaminoglycans
are linear polysaccharides that participate in many biological processes by interacting with
a wide range of proteins [1]. Heparin is a highly sulfated glycosaminoglycan found in most
organisms and is widely used as an anticoagulant to treat thrombosis, thrombophlebitis,
and embolism [2].
There is a strong interest in finding new heparin- binding proteins and peptide
sequences in order to develop new treatment methods for many diseases. To support the
above task, we have applied the Support Vector Machine (SVM) [3-5] approach, a
supervised machine learning method, to build a prediction model. The model takes in the
primary structure (amino acid sequence information) of a protein and determines if the
protein is heparin-binding or not.
Background
Biological Background:
Proteins are comprised of amino acids. These amino acids are strung together in an
amino acid chain, which makes up the primary structure of a protein. The primary
structure contains a lot of relevant data pertaining to the features and characteristics of its
protein. An amino acid chain is a specific consecutive sequence of amino acids found in a
protein. There are only 20 natural distinct amino acids found in proteins. From a computer
science standpoint, a protein’s primary structure is often represented in the format of a
string of capital letters, where each letter maps to one of the 20 natural amino acids. For
example, the amino acid sequence Alanine-Cysteine-Alanine-Glycine would correspond to
the following string ‘ACAG’, where Alanine maps to the letter ‘A’, Cysteine maps to the letter
‘C’, and Glycine maps to the letter ‘G’.
Available structural information on heparin-binding proteins (HBPs) reveals that
heparin binds to a binding pocket consisting of positively charged amino acids
(lysine/arginine/histidine) [6]. An XB pattern is a string of X and B, where B stands for the
3 basic amino acids (lysine/arginine/histidine) and X stands for the remaining 17 of the 20
natural amino acids. Based on information given by the structures of fibroblast growth
factors (FGFs) (proteins that interact with heparin during their cell signaling process), it is
known that the selective distribution of the basic amino acids is important for heparin
affinity and interaction. Based on the 3-dimensional structures of other heparin-binding
proteins, consensus or signature heparin-binding sequences (strings) have been found to
occur in these proteins that are thought to be required for their interaction with heparin.
The two main pattern strings are XBBXBX and XBBBXXBX [7]. These two patterns and
another 17 patterns are further investigated in their occurrences in heparin-binding
proteins [8], as are other commonly occurring patterns.
Computer Science Background:
In the SVM based Supervised Machine Learning, samples are considered as points in
a higher dimensional space. In this case, the samples will be individual proteins. Each point
has a label that indicates to which of the two groups it belongs (in this case heparin-binding
protein group and non-heparin- binding protein group). Further, a set of training or
learning samples (usually half of the samples belong to one group and another half belongs
to the other group) are fed into the SVM learning algorithm. The algorithm attempts to
build a hyper plane that separates the learning samples into the two groups. Samples

belonging to the same group can be expected to reside on one side of the hyper plane and
consequently the hyper plane becomes the classifier or the prediction model. It should be
noted that any hyper plane partitions a higher dimensional space into two parts, on either
sides of the hyper plane. To predict a new sample, the sample is transformed into a point in
the higher dimensional space. Then depending on which side of the hyper plane the point
ends up on, a prediction is made.
In a higher dimensional space, each dimension is a feature of the underlining sample
(in this case proteins are samples). In building a SVM based prediction model for heparinbinding proteins, we need to decide what features of proteins to use. In this study, we have
decided to use different combinations of XB patterns and other biological measurements as
features since, as stated above, the XB pattern occurrences in heparin- binding proteins
seem to suggest that their presence is important to the potential to bind. Additionally, other
biological indicators exist that could prove useful in the prediction. For example, heparin is
very negatively charged; therefore it is reasonable to believe the proteins with a more
positive charge may tend to bind more easily with Heparin. Thus, information regarding
the charges of the protein are also taken as possible features, as well as other measurable
information such as the amino acid chain’s length, hydrophobicity index, et cetera.
Contribution
Using XB patterns and biological measurements as features, a SVM based prediction
model for heparin-binding proteins is proposed and developed. The prediction is based on
sequence information or protein primary structure. The models achieve reasonable
prediction results and support the research effort of finding new heparin- binding proteins
and peptide sequences in order to develop new treatment methods for many diseases. As of
now, we are unaware of any other heparin-binding predictive models existing currently.
Approach

Figure 1 The process of creating the three predictive models from the initial training
proteins.
Data sample collection

The proteins used for training and testing were extracted from the UniProt database
[13]. One hundred and seventy four heparin binding proteins were gathered from the
database of polyanion-binding proteins (DB-PABP), and another one hundred and four
non-binding proteins were gathered from the UniProt database. Tables 1 and 2 list
examples of heparin binding and non-heparin binding proteins used in the testing and
training. A complete list of the proteins used can be found in the appendix.
Table 1 Examples of heparin binding proteins used in testing and training
Sequence Identifier
731717
307129
33959
1585498
340146

Description
Protein NSG1
hepatic lipase precursor
interleukin 8 [Homo sapiens]
diamine oxidase
urokinase

Table 2 Examples of non-heparin binding proteins used in testing and training
Sequence Identifier
O35400
Q15125
Q08462
P08842
P25697

Description
alcohol sulfotransferase
cholestenol DELTAisomerase
adenylate cyclase
steryl-sulfatase
phosphoribulokinase

The training set for the models consisted of 140 total proteins, which is about half of
the total protein sample size. The remaining proteins were part of the testing set, which
was used to determine accuracy. Of the 140 training proteins, 70 were known to be heparin
binding and the other 70 were known to be not heparin binding. The training set was
evenly distributed between binding and non-binding proteins in order to ensure the
models would be balanced in their construction.
Feature selection
For this research, two sets of features were used to create three predictive models.
One model corresponds to the first feature set, another corresponds to the second feature
set, and last model uses both feature sets combined. The two features sets were broken
down by approach; one feature set used commonly occurring XB patterns and the other
used likely biological metrics.
The software used for feature derivation consisted of python scripts. The python
scripts transfored the protein data from FASTA format into the desired feature values.

XB pattern feature set
A total of 66 features were used to map each protein to a point in a 66 dimensional
space. The feature values are calculated based on the number of occurrences of each
feature’s corresponding XB pattern in the protein’s primary amino acid sequence.
Therefore, our model only uses a protein’s primary sequence data to make the heparin
binding prediction.
Each protein has a primary structure, which is its sequence of amino acids. Each
amino acid has its own generalized pH level. Heparin is one of the mostly negatively
charged glycosaminoglycans, so it’s hypothesized that a larger volume of basic amino acids
are necessary in a protein for it to bind. A protein’s sequence can be reduced to the two
symbols B and X, where B represents the 3 basic amino acids (arginine, histidine, and
lysine) and X represents the 17 non-basic amino acids [9, 10, 2, 11]. Recent studies have
shown that heparin-binding proteins contain common XB pattern strings [8]. Thus, the XB
patterns present in a protein should be relevant to its potential to bind. The XB patterns
selected for the model are patterns that have been identified as being present in other
heparin binding proteins.
When deriving the XB features of a protein, it first has its primary structure
converted from a string of amino acid identifiers to a string of just Xs and Bs. Then, each of
the 66 XB pattern occurrences is individually summed and set to the corresponding feature
number (Feature 1 is the first XB pattern, Feature 2 is the second, and so on). A list of the
first 7 features and their corresponding XB patterns is listed in Table 3. A full list of the 66
and 19 XB patterns used can be found in the appendix.
Table 3 Example set of Features 1 – 7 and their XB patterns
Feature Number
1
2
3
4
5
6
7

XB pattern
XBXXBXBX
XBXBXXBX
XBBXBBX
XBBBXXBX
BBXXBBXX
XBBXXBBX
BXBXBBXB

Biological Metrics Feature set
The second feature set contained 129 features derived from the primary structures.
These features were measured using the Python library Biopython[14]. Table 4 gives
descriptions of the kinds of measurement used in the first 9 features. The remaining 120
features are 6 metrics applied for each of the 20 amino acids types present in the protein.
A full list of the 129 features can be found in the appendix and their code used can be
requested from the authors.

Table 4 Example descriptions for the first 9 biological features
Feature #
Feature #1
Feature #2
Feature #3
Feature #4
Feature #5
Feature #6
Feature #7
Feature #8
Feature #9

Desciption:
Charge of protein
Length of Protein Sequence
Molecular Weight
Aromaticity
Instability Index
Isoeletric Point
Helix Fraction
Turn Fraction
Sheet Fraction

Scaling the Features:
Every feature is represented by a number. For example, the XB features count
occurrences of XB patterns, so their feature value must be a positive integer. However, the
biological features may have vastly different values for their features. For example, the
molecular weight feature will likely be a very large four or five digit number, while the
Instability index feature will have a value less than 1. The large differences in the possible
values can lead to higher value features overshadowing the smaller valued ones.
To handle the various possible ranges of the feature values, all of the features were
scaled to fall within a range of [-1, +1]. This scaling helps the support vector machine
balance out the importance of each feature, to avoid features with large values dominating
ones with smaller values [3].
The Support Vector Machine:
In addition to the selected features, several aspects of the support vector machine
affect the accuracy of the model. These aspects include the kernel function type, the
function parameter, γ, and the soft margin parameter, C.
The kernel function translates the training data into higher dimensions so that the
training points can become linearly separable. After testing several different kernel
functions, the kernel function chosen for the SVM was the Gaussian radial basis function.
This kernel takes in a specified parameter 𝛾. The Gaussian function is as such:
2

𝐾(𝑥𝑖 , 𝑥𝑗 ) = exp (−𝛾 ∗ |𝑥𝑖 − 𝑥𝑗 | ) , 𝛾 > 0.
The soft margin parameter, C, (also called the penalty parameter) determines how
much variability in the computed hyperplane should be allowed. A larger C value will result
in a tighter bound, while a smaller C value would result in a more relaxed bound [4].
In order to help determine optimal γ and C values, the grid tool from LIBSVM, a
support vector machine library, was used [15]. The grid tool performs programmatic crossvalidation checks with various combinations of γ and C values to determine which yields
the best accuracy. These cross-validation checks are performed by separating the training

data into several subsets and then running a test in which half of the subsets are
considered the training set and the other half is considered the testing set. The cross
validation model is created using the training subsets and tested against the testing subsets
in order to achieve accuracy [12]. The values of (γ, C) which yielded the highest accuracy
were used in the models.
Model Validation:
In order to validate the model a testing protein data set was identified consisting of
the remaining 138 proteins not included in the training set. Of these, 105 of the proteins
were known heparin binding proteins, while the other 34 were known heparin nonbinding proteins.
A different set of LIBSVM functions was used to validate the model. The validation
was performed by first transforming the testing protein’s sequence data into the features
used by the model, scaling them, and then determining on which side of the dividing
hyperplane each protein is located. The proteins were then assigned a label, either +1 or -1,
to signify which set the protein was predicted to fall into, where the +1 set is the set of
heparin binding proteins and the -1 set is the set of heparin non-binding proteins. Each
newly predicted label is then compared to the protein’s known label. If the labels match,
then the prediction is considered successful. If the labels do not match, the prediction is
considered unsuccessful.
RESULTS
For this research 3 different models were created: one using the 129 biological
metrics features, one using the 66 XB pattern features, and another using a combination of
the 129 biological features and 19 of the most commonly occurring XB patterns in heparinbinding proteins. All of the models were trained using the same training set and all were
tested against the same testing set. The results of their accuracies are listed in Table 5
below.
Table 5 Model Accuracies and parameter values.

γ value
C value
Training Set
Accuracy
Testing Set
Accuracy
Combined
Accuracy

129 Bio Features
Model

66 XB Pattern Features
Model

Combined 129 Bio and
19 XB Feature model

1
0.886123
100% (140/140)

8
0.03125
99.28% (139/140)

2
0.03125
100% (140/140)

74.64% (103/138)

75.36% (104/138)

76.81% (106/138)

87.41% (243/278)

87.41% (243/278)

88.49% (246/278)

All the models tended to do well (close to 100% accuracy) predicting the Training
set. The Testing set was predicted with the highest accuracy in the combined model with an

accuracy of 76.81%, however the other two models were very close to it in accuracy as well.
The combined accuracy across the entire dataset was around 88% across all the models.
At this time we are unaware of any other heparin-binding prediction models, and
thus have no precedent to compare these results to.
CONCLUSIONS AND FUTURE WORK
A heparin-binding prediction model is proposed. It is a Support Vector Machine
based model using protein primary structure as input. The models consider XB pattern
frequency, biological indicators, or both as features at the present time. A preliminary
prototype system is developed that allows a user to provide an amino acid sequence, pick a
model, and then the system returns the prediction result to the user.
The models and the software described in this paper have demonstrated significant
potential in advancing research efforts of identifying new heparin- binding proteins via the
investigation and study of protein and peptide sequences as a means of developing new,
more effective treatment methods for many diseases. By using XB patterns as features, this
investigation provides additional insight into the role that XB patterns or motifs play in
proteins that bind to heparin.
To improve the prediction accuracy, we will investigate the selection of other XB
patterns and features beyond XB patterns such as chemical and physical properties of
amino acids. Since protein interaction and protein binding take place in 3-dimensional
space, including secondary and tertiary structural information would improve the accuracy
of the prediction model and will be studied.
Additionally, other types of machine learning techniques may yield better results to
this type of problem. However, given the limited dataset available for binding and nonbinding proteins, finding other suitable techniques may be difficult.
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Appendix
List of proteins used in this paper:
Training Set Proteins:
Heparin-binding Proteins:
>148747171 | adrenergic receptor, alpha 1a [Rattus norvegicus].
>730640 | 40S ribosomal protein S19.
>9082303 | amphoterin [Rattus norvegicus].
>2506872 | Fibronectin precursor (FN) (Cold-insoluble globulin) (CIG).
>37174 | thyroglobulin [Homo sapiens].
>6707677 | Probable eukaryotic translation initiation factor 3 30 kDa subunit (eIF-3 30 kDa) (eIF3j).
>56961643 | lipase, hepatic [Rattus norvegicus].
>112996 | Protein ABC1, mitochondrial precursor.
>220434 | heparin binding protein 44 [Mus musculus].
>74719685 | HSPC314.
>127115 | Midkine precursor (Retinoic acid-induced heparin-binding protein) (RI-HB).
>132876 | 60S ribosomal protein L30.
>2507249 | Cationic trypsin precursor (Beta-trypsin) [Contains: Alpha-trypsin chain 1; Alpha-trypsin chain 2].
>549657 | Uncharacterized TLC domain-containing protein YKL008C.
>758073 | complement factor H [Homo sapiens].
>549686 | Manganese resistance protein MNR2.
>139472860 | KCP [Human herpesvirus 8 type P].
>547759 | Tyrosine-protein kinase BTK (Bruton tyrosine kinase) (Agammaglobulinaemia tyrosine kinase) (ATK) (B
cell progenitor kinase) (BPK).
>34420140 | probasin [Rattus norvegicus].
>5852072 | L-selectin [Homo sapiens].
>52782792 | Probable ATP-dependent RNA helicase DDX47 (DEAD box protein 47).
>4506629 | ribosomal protein L29 [Homo sapiens].
>74752707 | CDNA: FLJ21054 fis, clone CAS00538 (Syncoilin, intermediate filament 1).
>1730882 | Probable transcriptional regulatory protein YPL133C.
>22653668 | Bromodomain adjacent to zinc finger domain protein 2B (hWALp4).
>184820 | insulin-like growth factor binding protein 5 [Homo sapiens].
>586485 | Uncharacterized acyltransferase YBR042C.
>74762678 | Tigger transposable element-derived protein 1.
>549725 | NADH-cytochrome b5 reductase precursor (p34/p32) [Contains: NADH-cytochrome b5 reductase p34
form; NADH-cytochrome b5 reductase p32 form].
>189578 | plasminogen activator inhibitor 1.
>50401123 | Probable ATP-dependent helicase LGP2 (Protein D11Lgp2 homolog).
>401413 | von Willebrand factor precursor (vWF) [Contains: von Willebrand antigen 2 (von Willebrand antigen II)].
>204572 | heparin-binding growth associated molecule.
>465514 | Putative deoxyribonuclease YBL055C.
>554477 | neural cell adhesion molecule.
>731597 | OTU domain-containing protein 2.
>89276751 | alpha 1 type V collagen preproprotein [Homo sapiens].
>27923749 | Centaurin-alpha 2.
>4033508 | Annexin A5 (Annexin-5) (Annexin V) (Lipocortin V) (Endonexin II) (Calphobindin I) (CBP-I) (Placental
anticoagulant protein I) (PAP-I) (PP4) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha)
(Anchorin CII).
>52000648 | Ubiquitin D (Ubiquitin-like protein FAT10) (Diubiquitin).
>48146225 | LPL [Homo sapiens].

>1169344 | Dimethyladenosine transferase (S-adenosylmethionine-6-N&rsquo, N&rsquo -adenosyl(rRNA)
dimethyltransferase) (18S rRNA dimethylase).
>34420913 | P-selectin [Homo sapiens].
>38045915 | pregnancy-associated plasma protein A preproprotein [Homo sapiens].
>42558987 | Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding
protein 2) (PTPRF-interacting protein-binding protein 2).
>62988324 | tenascin N [Homo sapiens].
>399356 | tRNA pseudouridine synthase 3 (tRNA-uridine isomerase 3) (tRNA pseudouridylate synthase 3)
(Depressed growth-rate protein DEG1).
>1708405 | Isocitrate dehydrogenase [NADP] (Oxalosuccinate decarboxylase) (IDH) (NADP(+)-specific ICDH) (IDP).
>731842 | Uncharacterized protein YIL091C.
>52783333 | Probable ribosome biogenesis protein RLP24 (Ribosomal protein L24-like).
>223002 | fibrin beta.
>731778 | Peroxiredoxin DOT5 (Thioredoxin reductase) (Nuclear thiol peroxidase) (nTPx) (Disrupter of telomere
silencing protein 5).
>129724 | Platelet-derived growth factor B chain precursor (PDGF B-chain) (Platelet-derived growth factor beta
polypeptide) (PDGF-2) (c-sis) (Becaplermin).
>6226778 | Bone morphogenetic protein receptor type IB precursor (CDw293 antigen).
>143811458 | Sentrin-specific protease 2 (Sentrin/SUMO-specific protease SENP2) (SMT3-specific isopeptidase 2)
(Smt3ip2) (Axam2).
>4699844 | Chain A, Crystal Structure Of Heparin And Integrin Binding Segment Of Human Fibronectin.
>122742 | Heparin-binding growth factor 2 precursor (HBGF-2) (Basic fibroblast growth factor) (BFGF)
(Prostatropin).
>38154680 | lactoferrin [Homo sapiens].
>74734322 | BM022.
>20149543 | placental growth factor, vascular endothelial growth factor-related protein [Homo sapiens].
>49066024 | Uncharacterized protein YCR016W.
>117168301 | laminin, alpha 1 precursor [Mus musculus].
>6175077 | Small inducible cytokine A5 precursor (CCL5) (T-cell-specific RANTES protein) (SIS-delta) (T cell-specific
protein P228) (TCP228) [Contains: RANTES(3-68); RANTES(4-68)].
>12644361 | Seminal plasma protein BSP-30 kDa precursor (BSP-30K).
>183951 | heparin binding protein.
>731827 | Mitochondrial acidic protein MAM33, mitochondrial precursor.
>13549118 | platelet factor 4 [Homo sapiens].
>3915598 | DNA-3-methyladenine glycosylase (3-methyladenine DNA glycosidase) (ADPG) (3-alkyladenine DNA
glycosylase) (N-methylpurine-DNA glycosylase).
>47523194 | sperm associated AWN protein [Sus scrofa].
>133796 | 40S ribosomal protein S15 (RIG protein).

Non-heparin binding proteins:
>Phosphatidylinositol 4-kinase alpha (P42356)
>Cullin-2, homo sapiens
>P79896|S-(hydroxymethyl)glutathione dehydrogenase|EC 1.1.1.284|Sparus aurata|Swiss-Prot
>Ras-related protein Rab-22A, Homo sapiens
>P98005|cytochrome-c oxidase|EC 1.9.3.1|Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579)|SwissProt
>Q92T88|methylenetetrahydrofolate dehydrogenase (NADP+)|EC 1.5.1.5|Rhizobium meliloti (strain 1021)|SwissProt
>hexokinase
>C9M0C5|purine nucleosidase|EC 3.2.2.1|Lactobacillus helveticus DSM 20075|TrEMBL
>Protein FADD, Homo sapiens
>P31414|inorganic diphosphatase|EC 3.6.1.1|Arabidopsis thaliana|Swiss-Prot
>Nuclear factor NF-kappa-B p100 subunit, Homo sapiens

>Transforming growth factor beta-1, Homo sapiens
>neuron-specific vesicular protein calcyon, Homo sapiens
>Succinate dehydrogenase [ubiquinone] flavoprotein subunit (P31040)
>A9WLH9|Glutarate-CoA ligase|EC 6.2.1.6|Renibacterium salmoninarum (strain ATCC 33209 / DSM 20767 / JCM
11484 / NBRC 15589 / NCIMB 2235)|TrEMBL
>Inhibin beta A chain, Homo sapiens
>O35400|alcohol sulfotransferase|EC 2.8.2.2|Mus musculus|Swiss-Prot
>Catenin alpha-2, Homo sapiens
>Phosducin, Bos taurus
>Kinesin family member 5, Dictyostelium discoideum
>Q15125|cholestenol DELTA-isomerase|EC 5.3.3.5|Homo sapiens|Swiss-Prot
>Rap guanine nucleotide exchange factor 2, Homo sapiens
>Beta-arrestin-1, Homo sapiens
>Maleate isomerase (O24766)
>Q08462|adenylate cyclase|EC 4.6.1.1|Homo sapiens|Swiss-Prot
>Paxillin, Homo sapiens
>A7GPY3|kynureninase|EC 3.7.1.3|Bacillus cereus subsp. cytotoxis (strain NVH 391-98)|Swiss-Prot
>P28332|alcohol dehydrogenase|EC 1.1.1.1|Homo sapiens|Swiss-Prot
>BH3-interacting domain death agonist, Homo sapiens
> Insulin receptor substrate 1, Homo sapiens
>Acetoacetyl-CoA reductase/transferase (P07097)
>P17516|3alpha-hydroxysteroid dehydrogenase (B-specific)|EC 1.1.1.50|Homo sapiens|Swiss-Prot
>Protein TOB2, Homo sapiens
>P47985|ubiquinol-cytochrome-c reductase|EC 1.10.2.2|Homo sapiens|Swiss-Prot
>P22570|ferredoxin-NADP+ reductase|EC 1.18.1.2|Homo sapiens|Swiss-Prot
>Follistatin, Homo sapiens
>Cyclic AMP-responsive element-binding protein 3, Homo sapiens
>Phosphatidylinositol 4-kinase beta (Q9UBF8)
>Tumor necrosis factor, Homo sapiens
>P08842|steryl-sulfatase|EC 3.1.6.2|Homo sapiens|Swiss-Prot
>Protein BTG3, Homo sapiens
>Monoamine oxidase, Homo sapiens
>RAR-related orphan receptor alpha, mouse
>C-X-C motif chemokine 10, Macaca nemestrina
>C4IU24|glyoxylate oxidase|EC 1.2.3.5|Brucella abortus str. 2308 A|TrEMBL
>ORAI calcium release-activated calcium modulator 2
>Disintegrin and metalloproteinase domain-containing protein 17, Homo sapiens
>P48449|Lanosterol synthase|EC 5.4.99.7|Homo sapiens|Swiss-Prot
>Tumor necrosis factor receptor superfamily member 13B, homo sapiens
>P25697|phosphoribulokinase|EC 2.7.1.19|Arabidopsis thaliana|Swiss-Prot
>Nuclear factor NF-kappa-B p105 subunit, Homo sapiens
>Histidine-containing phosphotransfer protein 5, Arabidopsis thaliana
>P17174|aspartate transaminase|EC 2.6.1.1|Homo sapiens|Swiss-Prot
>DNA helicase, Homo sapiens
>P55217|cystathionine gamma-synthase|EC 2.5.1.48|Arabidopsis thaliana|Swiss-Prot
>Mitogen-activated protein kinase kinase kinase 7, Homo sapiens
>Dopachrome isomerase, Homo sapiens
>Q03248|beta-ureidopropionase|EC 3.5.1.6|Rattus norvegicus|Swiss-Prot
>C6EF07|formate dehydrogenase-N|EC 1.1.5.6|Escherichia coli (strain B / BL21-DE3)|TrEMBL
>Mitogen-acivated protein kinase 1, Homo sapiens
>Signal recognition particle receptor FtsY, Escherichia coli (strain K12)
>B7J403|biotin synthase|EC 2.8.1.6|Acidithiobacillus ferrooxidans (strain ATCC 23270 / DSM 14882 / NCIB
8455)|Swiss-Prot

>Q9DBT5|AMP deaminase|EC 3.5.4.6|Mus musculus|Swiss-Prot
>Cryptochrome-1, Homo sapiens
>A3MHE3|arylformamidase|EC 3.5.1.9|Burkholderia mallei (strain NCTC 10247)|Swiss-Prot
>Bone morphogenetic protein 2, Homo sapiens
>P0CH37|alcohol dehydrogenase (NADP+)|EC 1.1.1.2|Mycobacterium smegmatis (strain ATCC 700084 /
mc(2)155)|Swiss-Prot
>P0A2E2|glycine hydroxymethyltransferase|EC 2.1.2.1|Salmonella typhi|Swiss-Prot
>Bile acid-CoA:amino acid N-acyltransferase, Homo sapiens
>Mesaconyl-CoA hydratase OS=Methylobacterium extorquens

Testing Set:
Heparin Binding proteins:
>730057 | Suppressor protein STM1 (GU4 nucleic-binding protein 2) (G4p2 protein) (Triplex-binding protein 1)
(3BP1) (Ribosomal subunits association factor) (AF) (POP2 multicopy suppressor protein 4) (TOM1 suppressor
protein 1).
>461847 | Cleavage stimulation factor 64 kDa subunit (CSTF 64 kDa subunit) (CF-1 64 kDa subunit) (CstF-64).
>731705 | TPR repeat-containing protein YHR117W.
>17865670 | 26S protease regulatory subunit 4 (P26s4).
>68534974 | AQN-1 protein [Sus scrofa].
>84028283 | Probable ATP-dependent helicase YFR038W.
>135100 | Aspartyl-tRNA synthetase, cytoplasmic (Aspartate--tRNA ligase) (AspRS).
>116242826 | Tripartite motif-containing protein 41.
>134104968 | Chain A, Structure Of Cxcl12:heparin Disaccharide Complex.
>20141972 | WD-repeat protein 5 (WD-repeat protein BIG-3).
>6094485 | Rho guanine nucleotide exchange factor 5 (Guanine nucleotide regulatory protein TIM) (Oncogene
TIM) (p60 TIM) (Transforming immortalized mammary oncogene).
>538354 | thrombospondin.
>74731080 | Uncharacterized protein C11orf52.
>114083 | Carbohydrate-binding protein AQN-3 (Zona pellucida-binding protein AQN-3) (Spermadhesin AQN-3).
>585379 | La protein homolog (La ribonucleoprotein) (La autoantigen homolog).
>2499599 | Mitogen-activated protein kinase 7 (Extracellular signal-regulated kinase 5) (ERK-5) (ERK4) (BMK1
kinase).
>74718607 | CDNA: FLJ21319 fis, clone COL02312.
>4506105 | prolactin [Homo sapiens].
>3127926 | collagen type VI, alpha 3 chain [Homo sapiens].
>546321 | protein C inhibitor; PCI [Homo sapiens].
>6649952 | bone morphogenetic protein 2 [Homo sapiens].
>4503413 | heparin-binding EGF-like growth factor [Homo sapiens].
>73858566 | heparin cofactor II precursor [Homo sapiens].
>1703371 | Sterol O-acyltransferase 2 (Sterol-ester synthase 2).
>113936 | Antithrombin-III precursor (ATIII).
>339741 | tumor necrosis factor.
>71152337 | Cdc42 effector protein 2 (Binder of Rho GTPases 1).
>730684 | E3 ubiquitin--protein ligase RSP5 (Reverses SPT-phenotype protein 5).
>4502461 | betacellulin [Homo sapiens].
>2498865 | rRNA biogenesis protein RRP5 (Ribosomal RNA-processing protein 5).
>74723962 | FLJ00195 protein.
>88853069 | vitronectin precursor [Homo sapiens].
>2497100 | Mitochondrial protein YML030W.
>74732911 | Within bgcn homolog (Drosophila).
>731815 | Hypothetical 19.2 kDa protein in SNP1-GPP1 intergenic region.
>1585498 | diamine oxidase.

>123509 | Heptapoietin A light chain (HPTA).
>1340171 | C4b-binding protein [Homo sapiens].
>6016557 | Melanoma-associated antigen B4 (MAGE-B4 antigen).
>116242759 | Rho GTPase-activating protein 4 (Rho-GAP hematopoietic protein C1) (p115).
>83721970 | sperm adhesion molecule 1 [Bos taurus].
>125259 | Casein kinase II subunit alpha (CK II alpha subunit).
>75428248 | Heparinase II protein precursor.
>730687 | 40S ribosomal protein S20.
>2500537 | ATP-dependent RNA helicase HAS1 (Helicase associated with SET1 protein 1).
>120549 | Follistatin precursor (FS) (Activin-binding protein).
>1723655 | Uncharacterized membrane protein YGR026W.
>1709190 | Sorting nexin MVP1.
>19856774 | Transcription factor EB.
>1168246 | Alpha-1A adrenergic receptor (Alpha 1A-adrenoceptor) (Alpha 1A-adrenoreceptor) (Alpha-1C
adrenergic receptor) (Alpha adrenergic receptor 1c).
>4557727 | lipoprotein lipase precursor [Homo sapiens].
>8394103 | pleiotrophin [Rattus norvegicus].
>20455481 | Voltage-dependent L-type calcium channel subunit beta-1 (CAB1) (Calcium channel voltagedependent subunit beta 1).
>118823 | Dolichol-phosphate mannosyltransferase (Dolichol-phosphate mannose synthase) (Dolichyl-phosphate
beta-D-mannosyltransferase) (Mannose-P-dolichol synthase) (MPD synthase) (DPM synthase).
>134509 | Protein SIS1.
>145559466 | Probable ATP-dependent RNA helicase DDX43 (DEAD box protein 43) (DEAD box protein HAGE)
(Helical antigen).
>62901400 | Vacuolar protein sorting-associated protein 66.
>116242631 | M-phase inducer phosphatase 3 (Dual specificity phosphatase Cdc25C).
>732161 | Hypothetical 55.9 kDa protein in MDS1-RPL13B intergenic region.
>15680217 | Cathepsin G [Homo sapiens].
>129719 | Platelet-derived growth factor A chain precursor (PDGF A-chain) (Platelet-derived growth factor alpha
polypeptide) (PDGF-1).
>74761986 | HSD-4 protein.
>62288846 | PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein).
>586408 | tRNA (cytosine-5-)-methyltransferase NCL1 (Trm4) (Multisite-specific tRNA:m5C-methyltransferase).
>1351928 | Methionine aminopeptidase 1 precursor (MetAP 1) (MAP 1) (Peptidase M 1).
>1711571 | RNA polymerase II transcriptional coactivator SUB1.
>4505849 | phospholipase A2, group IIA [Homo sapiens].
>113950 | Annexin A2 (Annexin II) (Lipocortin II) (Calpactin I heavy chain) (Chromobindin-8) (p36) (Protein I)
(Placental anticoagulant protein IV) (PAP-IV).
>135807 | Prothrombin precursor (Coagulation factor II) [Contains: Activation peptide fragment 1; Activation
peptide fragment 2; Thrombin light chain; Thrombin heavy chain].
>33959 | interleukin 8 [Homo sapiens].
>47523176 | porcine seminal protein I [Sus scrofa].
>133017 | 60S ribosomal protein L8-A (L4) (L4-2) (YL5) (RP6) (L7a-1) (Maintenance of killer protein 7).
>62243248 | insulin-like growth factor binding protein 3 isoform a precursor [Homo sapiens].
>307129 | hepatic lipase precursor.
>386853 | kininogen [Homo sapiens].
>1717874 | Ubiquitin carboxyl-terminal hydrolase 10 (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing
protease 10) (Deubiquitinating enzyme 10) (Disrupter of telomere silencing protein 4).
>119675632 | mast cell-restricted serine protease 7 [Mus musculus].
>120049 | Fibroblast growth factor receptor 2 precursor (FGFR-2) (Keratinocyte growth factor receptor 2) (CD332
antigen).
>11342670 | azurocidin 1 preproprotein [Homo sapiens].
>30172886 | Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic).

>2498960 | Ribosome biogenesis protein SSF2.
>2495255 | Non-histone protein 10 (High mobility group protein 2).
>731717 | Protein NSG1.
>1730165 | GU4 nucleic-binding protein 1 (G4p1 protein) (P42) (Protein ARC1).
>64654689 | Parathyroid hormone [Homo sapiens].
>84027749 | Uncharacterized protein YLR211C.
>462299 | Meiosis-specific protein HOP1.
>2280514 | histidine-rich glycoprotein [Homo sapiens].
>125932 | Tissue factor pathway inhibitor precursor (TFPI) (Lipoprotein-associated coagulation inhibitor) (LACI)
(Extrinsic pathway inhibitor) (EPI).
>565136 | extracellular superoxide dismutase; EC-SOD [Homo sapiens].
>441174 | tissue plasminogen activator [Homo sapiens].
>153285461 | fibroblast growth factor 2 [Homo sapiens].
>547995 | Nucleosome assembly protein.
>122737 | Heparin-binding growth factor 1 precursor (HBGF-1) (Acidic fibroblast growth factor) (aFGF) (Betaendothelial cell growth factor) (ECGF-beta).
>74732608 | Apoptosis-inducing factor 3 (Apoptosis-inducing factor-like protein).
>123116 | Hepatocyte growth factor precursor (Scatter factor) (SF) (Hepatopoeitin-A) [Contains: Hepatocyte
growth factor alpha chain; Hepatocyte growth factor beta chain].
>74735535 | KIAA0731 protein.
>585880 | 60S ribosomal protein L4-A (L2) (YL2) (RP2).
>416746 | Azurocidin precursor (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP).
>50400820 | Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3).
>136242 | N(2),N(2)-dimethylguanosine tRNA methyltransferase, mitochondrial precursor (tRNA(guanine-26,N(2)N(2)) methyltransferase) (tRNA 2,2-dimethylguanosine-26 methyltransferase)
(tRNA(m(2,2)G26)dimethyltransferase).
>119161 | Elongation factor 1-alpha (EF-1-alpha) (Translation elongation factor 1A) (Eukaryotic elongation factor
1A) (eEF1A).
>340146 | urokinase.
>1703084 | Acyl-CoA desaturase 1 (Stearoyl-CoA desaturase 1) (Fatty acid desaturase 1).
>416733 | C4b-binding protein alpha chain precursor (C4bp) (Proline-rich protein) (PRP).

Non-heparin binding:
>399508 | Peroxisomal hydratase-dehydrogenase-epimerase (HDE) (Multifunctional beta-oxidation protein) (MFP)
[Includes: 2-enoyl-CoA hydratase ; D-3-hydroxyacyl CoA dehydrogenase ].
>Protein Kinase C, Homo sapiens
>Tissue factor pathway inhibitor, Homo sapiens
>RIO-type serine/threonine-protein kinase Rio2, Archaeoglobus fulgidus
>Histatin-1, Homo sapiens
>Clathrin, light chain A, Homo sapiens
>Q7X9A6|plastoquinol-plastocyanin reductase|EC 1.10.9.1|Triticum aestivum|Swiss-Prot
>P53537|phosphorylase|EC 2.4.1.1|Vicia faba|Swiss-Prot
>Cyclin A-2, Homo sapiens
>Autophagy-related protein 3, Saccharomyces cerevisiae
>B0CEX1|Triose-phosphate isomerase|EC 5.3.1.1|Acaryochloris marina (strain MBIC 11017)|Swiss-Prot
>Mannose-binding lectin (protein C), Homo sapiens
>Q969G6|riboflavin kinase|EC 2.7.1.26|Homo sapiens|Swiss-Prot
>Q6UWM9|glucuronosyltransferase|EC 2.4.1.17|Homo sapiens|Swiss-Prot
>Q9BUT1|3-hydroxybutyrate dehydrogenase|EC 1.1.1.30|Homo sapiens|Swiss-Prot
>Caspase 8 (apoptosis-related cysteine peptidase), Danio rerio
>P20817|alkane 1-monooxygenase|EC 1.14.15.3|Rattus norvegicus|Swiss-Prot
>Proteasome maturation protein, Bos taurus
>Q96AT9|ribulose-phosphate 3-epimerase|EC 5.1.3.1|Homo sapiens|Swiss-Prot

>P10760|adenosylhomocysteinase|EC 3.3.1.1|Rattus norvegicus|Swiss-Prot
>Jun proto-oncogene (transcription factor AP-1), homo sapiens
>Cellular tumor antigen p53, Homo sapiens
>Vasopressin V1a receptor, Homo sapiens
>starch phosphorylase (Q9LIB2)
>Q9M643|Cycloeucalenol cycloisomerase|EC 5.5.1.9|Arabidopsis thaliana|Swiss-Prot
>Pancreatic lipase, Homo sapiens
>P22314|ubiquitin-activating enzyme|EC 6.3.2.B1|Homo sapiens|Swiss-Prot
>Q7Z5Q5|DNA-directed DNA polymerase|EC 2.7.7.7|Homo sapiens|Swiss-Prot
>Recoverin, Homo sapiens
>60S ribosomal protein L21, Homo sapiens
>Phospholipase C (P0C216)
>3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
>P58966|(R)-citramalate synthase|EC 2.3.1.182|Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 /
Go1 / JCM 11833 / OCM 88)|Swiss-Prot
>P14893|steroid DELTA-isomerase|EC 5.3.3.1|Bos taurus|Swiss-Prot

XB Patterns:
19 Most Occurring Patterns:
XBXBXXX
XXBXB
BXBXXXX
BXBXXX
XBXBX
XXBXBX
XBXB
XBXBXX
XBXX
BXBB
XBXBXXXX
XXBXBXXX
XXBXBXX
XXXBXB
BXXB
XXXXXXXXXXB
XXXXXXXXXXXB
XBXXX
XBXXXX

66 XB patterns:
XBXXBXBX
XBXBXXBX
XBBXBBX
XBBBXXBX
BBXXBBXX
XBBXXBBX
BXBXBBXB
XBBBXXBX
BBBBBXXXXX
XXBBXX
BXBXXX
XBBXXX

XBXBXX
BXXXXB
XXXXBB
XXXBXB
XXXBBX
BXXXBX
BBXXXX
XXBXXB
XBXXXB
XXBXBX
XBXXBX
BXXBXX
BBBXXX
XBBBXX
XXBBBX
XXXBBB
BXXXBB
XXBXBB
XBXXBB
BXXBBX
BXXBXB
BXBXXB
BBXXXB
BXBBXX
BXBXBX
XBXBXB
BBXXBX
BBXBXX
XBXBBX
XBXXBB
XXBBXB
XBBXBX
XBBBBX
XXBBBB
BBBBXX
BXBBBX
BXXBBB
BXBBXB
BBXXBB
XBXBBB
BBXBXB
BBXXBB
BBXBBX
BXBBBX
BBBXBX
BBBXXB
XBBXBB
BBBBBX
BBBBXB
BBBXBB
BBXBBB
BXBBBB
XBBBBB

BBBBBB

129 Biological Features:

Feature #

Feature Description

Feature 1

Charge of the Protein

Feature 2

Length of protein sequence

Feature 3

Molecular weight

Feature 4

Aromaticity

Feature 5

Instability Index

Feature 6

Isoeletric point

Feature 7

Helix fraction

Feature 8

Turn fraction

Feature 9

Sheet fraction

Features 10 – 29

Amino acid composition
percentage

Features 30 – 49

Kyte & Doolittle index of
hydrophobicity

Features 50 – 69

Flexibility

Features 70 – 89

Hopp & Wood of hydrophilicity

Features 90 – 109

Emini Surface fractional
probability

Features 110 – 129

Janin Interior to surface transfer
energy scale

